Chemoinformaics analysis of DOCECA-2E,4E,8Z,10E/Z-TETRAENOIC-ACID-ISOBUTYLAMIDES
| Molecular Weight | 338.576 | nRot | 19 |
| Heavy Atom Molecular Weight | 296.24 | nRig | 2 |
| Exact Molecular Weight | 338.318 | nRing | 0 |
| Solubility: LogS | -6.266 | nHRing | 0 |
| Solubility: LogP | 8.869 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 66 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 24 | No. of Aromatic Carbocycles | 0 |
| nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 22 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
| nHA | 1 | APOL | 66.3493 |
| nHD | 1 | BPOL | 43.0027 |
| QED | 0.194 |
| Synth | 2.191 |
| Natural Product Likeliness | 0.876 |
| NR-PPAR-gamma | 0.965 |
| Lipinski | Accepted |
| Pfizer | Rejected |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0 |
| Pgp-sub | 0 |
| HIA | 0.009 |
| CACO-2 | -5.011 |
| MDCK | 0.0000177 |
| BBB | 0.03 |
| PPB | 0.992524 |
| VDSS | 0.995 |
| FU | 0.00974786 |
| CYP1A2-inh | 0.218 |
| CYP1A2-sub | 0.158 |
| CYP2c19-inh | 0.279 |
| CYP2c19-sub | 0.056 |
| CYP2c9-inh | 0.109 |
| CYP2c9-sub | 0.992 |
| CYP2d6-inh | 0.008 |
| CYP2d6-sub | 0.035 |
| CYP3a4-inh | 0.088 |
| CYP3a4-sub | 0.01 |
| CL | 2.759 |
| T12 | 0.271 |
| hERG | 0.072 |
| Ames | 0.004 |
| ROA | 0.009 |
| SkinSen | 0.959 |
| Carcinogencity | 0.072 |
| EI | 0.968 |
| Respiratory | 0.8 |
| NR-Aromatase | 0.325 |
| Antiviral | No |
| Prediction | 0.575712 |